المؤلفون: Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels

المصدر: Zweegman , S , Stege , C A M , Haukas , E , Schjesvold , F H , Levin , M-D , Waage , A , Leys , R B L , Klein , S K , Szatkowski , D , Axelsson , P , Hieu Do , T , Knut-Bojanowska , D , van der Spek , E , Svirskaite , A , Klostergaard , A , Salomo , M , Blimark , C , Ypma , P F , Mellqvist , U-H , Poddighe , P J , Stevens-Kroef , M , van de Donk , ....

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Boron Compounds, Bortezomib/therapeutic use, Dexamethasone/therapeutic use, Glycine/analogs & derivatives, Hematopoietic Stem Cell Transplantation, Humans, Multiple Myeloma/diagnosis, Stem Cell Transplantation, Thalidomide/therapeutic use, Transplantation, Autologous, Treatment Outcome

الإتاحة: https://doi.org/10.3324/haematol.2019.240374Test
http://hdl.handle.net/11370/f3f7db9f-1279-46df-a761-05b10af58484Test
https://research.rug.nl/en/publications/ixazomibthalidomidelow-dose-dexamethasone-induction-followed-by-maintenance-therapy-with-ixazomib-or-placebo-in-newly-diagnosed-multiple-myeloma-patients-not-eligible-for-autologous-stem-cell-transplantation-results-from-the-randomized-phase-ii-hovon126nmsg-2113-trialTest(f3f7db9f-1279-46df-a761-05b10af58484).html

المؤلفون: Zweegman, Sonja, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M J, Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette W G, Deenik, Wendy, Gruber, Astrid, Coenen, Juleon L L M, Plesner, Torben, Klein, Saskia K, Tanis, Bea C, Szatkowski, Damian L, Brouwer, Rolf E, Westerman, Matthijs, Leys, M Rineke B L, Sinnige, Harm A M, Haukås, Einar, van der Hem, Klaas G, Durian, Marc F, Mattijssen, E Vera J M, van de Donk, Niels W C J, Stevens-Kroef, Marian J P L, Sonneveld, Pieter, Waage, Anders

المصدر: Zweegman , S , van der Holt , B , Mellqvist , U-H , Salomo , M , Bos , G M J , Levin , M-D , Visser-Wisselaar , H , Hansson , M , van der Velden , A W G , Deenik , W , Gruber , A , Coenen , J L L M , Plesner , T , Klein , S K , Tanis , B C , Szatkowski , D L , Brouwer , R E , Westerman , M , Leys , M R B L , Sinnige , H A M ....

مصطلحات موضوعية: Aged, 80 and over, Disease-Free Survival, Female, Humans, Lenalidomide, Maintenance Chemotherapy, Male, Melphalan/adverse effects, Middle Aged, Multiple Myeloma/drug therapy, Prednisone, Thalidomide/adverse effects, Treatment Outcome, Withholding Treatment

الإتاحة: https://doi.org/10.1182/blood-2015-11-679415Test
http://hdl.handle.net/11370/89ca85a9-5d00-480c-b9e8-4a4836a12e93Test
https://research.rug.nl/en/publications/melphalan-prednisone-and-lenalidomide-versus-melphalan-prednisone-and-thalidomide-in-untreated-multiple-myelomaTest(89ca85a9-5d00-480c-b9e8-4a4836a12e93).html